Journal

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

Read time: 1 mins

Published:16th Aug 2015

Author: Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F et al.

Source: Clinical and Translational Allergy

Availability: Free full text

Ref.:Clin Transl Allergy. 2015; 5: 29.

DOI:10.1186/s13601-015-0072-9

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H₁-antihistamines. So far, the humanistic, societal and economic burden of CSU/CIU has not been well quantified. Therefore it is important to broaden our understanding of how CSU/CIU impacts patients, society, and healthcare systems, by determining the disease burden of CSU/CIU and the associated unmet need; as well as to further guide the use of new treatments in an efficient and cost-effective manner.

Read abstract on library site Access full article